Supplementary Table 2 | Optimizing the multi-scale feature vector. We optimized the multiscale feature vector on a training set of 50,000 matched transcription start sites and control regions. Optimization was performed after fixing the data regularization settings at an optimal value on a simple feature vector.
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Comparison between methods for TRE identification
Mapping the location and activity of transcriptional regulatory elements (TREs) is a major challenge in understand how DNA sequences encode complex living organisms. TREs cannot generally be identified from DNA sequences alone, owing to their short lengths, diversity of form, and low information content. As a result, this problem has primarily been addressed using high-throughput functional genomic assays that provide indirect evidence of regulatory function, such as chromatin immunoprecipitation of bound transcription factors (TFs), histone modifications associated with transcriptional regulation, or DNase-I hypersensivity (DNase-Iseq). Recently it has become clear that another defining characteristic of TREs is that they are frequently associated with local transcription. We have recently shown that global run-on and sequencing (GRO-seq) with enrichment for 5'-capped RNAs reveals patterns of divergent transcription that accurately mark active TREs
Here we present the detection of regulatory elements using GRO-seq (dREG), a novel software program which uses sensitive machine learning approaches to extract much the same information as the dedicated GRO-cap protocol using standard GRO-seq data. There are two ways in which dREG contributes substantially to existing methods for TRE identification:
(1) Using transcriptional activation to detect TREs identifies a smaller subset of regulatory sites which control the vast majority of gene expression.
(2) Together with dREG, PRO-seq now allows one genome-wide assay to identify TREs, gene expression levels, and numerous other aspects of gene regulation.
These benefits considerably decrease the cost, time, and difficulty of interrogating multiple aspects of gene regulation in a new cell type. Major applications of this new technology include interrogating limited samples, such as primary clinical isolates, or large-scale studies across hundreds or thousands of individual samples in so-called 'epigenome association studies'. In addition, as we discuss in detail in the main paper, dREG also presents unique insights into distinct classes of TREs that complements alternative data sources in interesting and useful ways. A detailed discussion of precisely how dREG improvises on alternative approaches that are widely used for TRE identification is provided in the following pages.
Chromatin Modification ChIP-seq, using either H3K27ac or H3K4me1:
-Conventional ChIP-seq protocols require starting with 1-20M cells for each immunoprecipitation. This large amount of input sample prevents these methods from scaling down to smaller sample quantities in clinical isolates, especially in cases where information from multiple experimental assays are desired.
-Although dREG has a high overlap with H3K27ac peaks, it covers less genomic area, more precisely defining regions that are active in transcriptional activation. H3K27ac peaks cover significantly more genomic area compared with dREG (nearly 2.7% of hg19 in K562 cells [H3K27ac], compared with ~1.8% [dREG] ). In spite of this larger genomic area, there are fewer H3K27ac peaks than dREG sites, and they tend to mark the same broad genomic coordinates. Thus, on average, each H3K27ac peak covers approximately one third more genomic area than dREG. This makes dREG a superior choice in a variety of applications, including TF binding site prediction and narrowing GWAS SNPs prior to functional validation. -Although H3K27ac detects active enhancers, dREG appears to be slightly more sensitive in this task. We find that dREG is present at 50% more of the distal enhancers that have DNase-seq signal, and either dREG or H3K27ac (but not both).
Chromatin accessibility assays (DNase-seq or ATAC-seq): -Chromatin accessibility does interrogate the transcriptional status of enhancers. Our analysis of eQTLs, GWAS SNPs, histone acetylation, and TF binding ( Fig. 2 and 4) , together with work from many others 2, 3 , demonstrates that eRNA transcription reflects the activity of enhancer elements, which is important for narrowing down the set of regulatory elements to those that are actively influencing gene expression.
-DNase-seq and ATAC-seq require isolating intact nuclei, which is often infeasible in tissue samples. The most recent version of PRO-seq can be applied without first completing a nuclear isolation, which will allow many important applications in primary clinical isolates.
GRO-seq with enrichment for 5' capped RNAs (GRO-cap):
-GRO-cap is a sensitive assay for detecting transcription initiation, and therefore the location of active TREs
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. GRO-cap is a more challenging assay than PRO-seq, and requires significantly more biological material as input.
-The amount of signal from each GRO-cap peak does not reflect gene expression (rather, it's influenced by the amount of paused Pol II). PRO-seq reads mapping to the gene body directly reflect expression levels, and correlate well with other measures of gene expression (e.g., RNA-seq).
Measuring gene expression levels requires preforming an additional assay:
-In most applications that map TREs genome-wide, investigators also want to measure gene expression levels. Each of the assays listed above must be run in combination with at least one additional experiment, either RNA-seq or PRO-seq, to measure gene expression levels.
Completing two (or more) separate sample and library preparation experiments increases the time and cost invested in each sample, which is problematic in many applications that demand extremely large sample sizes (e.g., epigenome mapping). Moreover, while RNA-seq is a powerful approach targeting the expression of protein coding genes and stable non-coding RNAs, it does not identify the location of unstable lincRNAs that are increasingly accepted to be involved in gene regulation 3 .
